High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out.
作者信息
Jarvis Joseph N, Boulle Andrew, Loyse Angela, Bicanic Tihana, Rebe Kevin, Williams Anthony, Harrison Thomas S, Meintjes Graeme
出版信息
AIDS. 2009 Jun 1;23(9):1182-3. doi: 10.1097/QAD.0b013e32832be0fc.
Abstract
摘要
相似文献
1
High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out.
AIDS. 2009 Jun 1;23(9):1182-3. doi: 10.1097/QAD.0b013e32832be0fc.
2
Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm.
BMC Infect Dis. 2020 Jan 20;20(1):61. doi: 10.1186/s12879-020-4798-1.
3
Is HIV-associated tuberculosis a risk factor for the development of cryptococcal disease?
AIDS. 2010 Feb 20;24(4):612-4. doi: 10.1097/QAD.0b013e32833547f7.
4
Decreasing incidence of cryptococcal meningitis in West Africa in the era of highly active antiretroviral therapy.
AIDS. 2012 May 15;26(8):1039-41. doi: 10.1097/QAD.0b013e328352d1d8.
5
Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
BMC Infect Dis. 2007 Dec 21;7:147. doi: 10.1186/1471-2334-7-147.
6
Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia.
Trop Med Int Health. 2010 Nov;15(11):1375-81. doi: 10.1111/j.1365-3156.2010.02622.x. Epub 2010 Sep 25.
7
Cryptococcal meningitis in a tertiary hospital in Pretoria, mortality and risk factors - A retrospective cohort study.
Int J STD AIDS. 2017 Apr;28(5):480-485. doi: 10.1177/0956462416653559. Epub 2016 Jul 10.
8
Epidemiology of adult meningitis during antiretroviral therapy scale-up in southern Africa: Results from the Botswana national meningitis survey.
J Infect. 2019 Sep;79(3):212-219. doi: 10.1016/j.jinf.2019.06.013. Epub 2019 Jun 28.
9
Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand.
J Int Assoc Provid AIDS Care. 2014 Sep-Oct;13(5):434-7. doi: 10.1177/2325957413500533. Epub 2013 Sep 3.
10
Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa.
J Infect. 2010 Jun;60(6):496-8. doi: 10.1016/j.jinf.2010.03.007. Epub 2010 Mar 20.
引用本文的文献
1
Systematic review on the compliance of WHO guidelines in the management of patients with advanced HIV disease in Africa: The case of cryptococcal antigen screening.
PLoS One. 2025 Jan 24;20(1):e0313453. doi: 10.1371/journal.pone.0313453. eCollection 2025.
2
Poor long-term outcomes despite improved hospital survival for patients with cryptococcal meningitis in rural, Northern Uganda.
PLoS One. 2024 May 21;19(5):e0303805. doi: 10.1371/journal.pone.0303805. eCollection 2024.
3
Fungal infections in Sudan: An underestimated health problem.
PLoS Negl Trop Dis. 2023 Sep 1;17(9):e0011464. doi: 10.1371/journal.pntd.0011464. eCollection 2023 Sep.
4
Antifungal activity of liriodenine on clinical strains of and species complexes.
J Venom Anim Toxins Incl Trop Dis. 2022 Sep 5;28:e20220006. doi: 10.1590/1678-9199-JVATITD-2022-0006. eCollection 2022.
5
High Burden of Cryptococcal Meningitis Among Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-Infected Patients in Northern Uganda in the Era of "Test and Treat": Implications for Cryptococcal Screening Programs.
Open Forum Infect Dis. 2022 Jan 10;9(2):ofac004. doi: 10.1093/ofid/ofac004. eCollection 2022 Feb.
6
Reimagining the future of African brain health: Perspectives for basic research on the pathogenesis of cryptococcal meningitis.
Brain Behav Immun Health. 2021 Nov 12;18:100388. doi: 10.1016/j.bbih.2021.100388. eCollection 2021 Dec.
7
Point of care tests for invasive fungal infections: a blueprint for increasing availability in Africa.
Ther Adv Infect Dis. 2021 Aug 16;8:20499361211034266. doi: 10.1177/20499361211034266. eCollection 2021 Jan-Dec.
8
Neurological deterioration in a patient with HIV-associated cryptococcal meningitis initially improving on antifungal treatment: a case report of coincidental racemose neurocysticercosis.
BMC Infect Dis. 2021 Jul 31;21(1):724. doi: 10.1186/s12879-021-06425-9.
9
Efficacy of induction regimens for cryptococcal meningitis in HIV-infected adults: a systematic review and network meta-analysis.
Sci Rep. 2021 Apr 21;11(1):8565. doi: 10.1038/s41598-021-87726-6.
10
MSG07: An International Cohort Study Comparing Epidemiology and Outcomes of Patients With Cryptococcus neoformans or Cryptococcus gattii Infections.
Clin Infect Dis. 2021 Oct 5;73(7):1133-1141. doi: 10.1093/cid/ciab268.
本文引用的文献
1
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.
AIDS. 2009 Feb 20;23(4):525-30. doi: 10.1097/QAD.0b013e328322ffac.
2
Antiretroviral therapy and early mortality in South Africa.
Bull World Health Organ. 2008 Sep;86(9):678-87. doi: 10.2471/blt.07.045294.
3
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
Clin Infect Dis. 2008 Jul 1;47(1):123-30. doi: 10.1086/588792.
4
Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy.
Clin Infect Dis. 2008 Jun 1;46(11):1694-701. doi: 10.1086/587667.
5
HIV-associated cryptococcal meningitis.
AIDS. 2007 Oct 18;21(16):2119-29. doi: 10.1097/QAD.0b013e3282a4a64d.
6
Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.
Clin Infect Dis. 2007 Jul 1;45(1):76-80. doi: 10.1086/518607. Epub 2007 May 25.
Zotero 插件